当前位置:首页 - 行情中心 - 华森制药(002907) - 财务分析

华森制药

(002907)

  

流通市值:43.46亿  总市值:58.76亿
流通股本:3.09亿   总股本:4.18亿

华森制药(002907)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.75亿元,每股收益0.18元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益165727.73万元,未分配利润68777.26万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产191171.63万元,负债25443.90万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入614,223,361.57417,852,265.17228,392,771.39691,542,793.48
营业总成本534,304,062.41361,848,490.3180,610,872.95655,558,798.19
营业利润89,054,863.3857,638,953.6848,045,398.1445,823,033.43
利润总额88,672,868.8157,200,244.2748,066,232.842,796,772.77
净利润74,576,835.6347,214,896.1240,351,252.0732,699,150.22
其他综合收益-173,845.46101,866.3528,420.147,047.57
综合收益总额74,402,990.1747,316,762.4740,379,672.1732,746,197.79
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,013,977,367.68958,850,580.15952,931,880.75894,638,934.15
非流动资产合计897,738,929.78916,988,241937,188,195.04956,814,954.99
资产总计1,911,716,297.461,875,838,821.151,890,120,075.791,851,453,889.14
流动负债合计207,532,333.4189,733,906.52188,799,032.52188,677,359.66
非流动负债合计46,906,649.5741,447,626.0243,020,363.6744,855,522.05
负债合计254,438,982.97231,181,532.54231,819,396.19233,532,881.71
归属于母公司股东权益合计1,657,277,314.491,644,657,288.611,658,300,679.61,617,921,007.43
股东权益合计1,657,277,314.491,644,657,288.611,658,300,679.61,617,921,007.43
负债和股东权益合计1,911,716,297.461,875,838,821.151,890,120,075.791,851,453,889.14
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计592,150,956.57392,933,932.67169,841,410.14858,415,352.54
经营活动现金流出小计485,270,379.52328,175,950.96160,984,714.1639,074,025.25
经营活动产生的现金流量净额106,880,577.0564,757,981.718,856,696.04219,341,327.29
投资活动现金流入小计214,694,231.323,621,625.89-862,762.1
投资活动现金流出小计452,000,526.19207,237,680.873,579,423.53158,207,192.36
投资活动产生的现金流量净额-237,306,294.89-183,616,054.98-3,579,423.53-157,344,430.26
筹资活动现金流入小计---70,200,000
筹资活动现金流出小计35,634,044.7220,980,015.7100,200100,429,463.01
筹资活动产生的现金流量净额-35,634,044.72-20,980,015.7-100,200-30,229,463.01
汇率变动对现金及现金等价物的影响-45,680.8826,460.877,308.3370,896.75
现金及现金等价物净增加额-166,105,443.44-139,811,628.15,184,380.8431,838,330.77
期末现金及现金等价物余额271,459,375.7297,753,191.04442,749,199.98437,564,819.14
TOP↑